scholarly article | Q13442814 |
P356 | DOI | 10.1530/JME-16-0013 |
P698 | PubMed publication ID | 26908835 |
P50 | author | Russell Prough | Q68001731 |
P2093 | author name string | Carolyn M Klinge | |
Barbara J Clark | |||
P2860 | cites work | Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. | Q53556298 |
Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen-Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP Cells | Q61347342 | ||
Induction of Hepatic Mitochondrial Glycerophosphate Dehydrogenase in Rats by Dehydroepiandrosterone1 | Q67905612 | ||
Therapeutic Effects of Dehydroepiandrosterone (DHEA) in Diabetic Mice | Q72777102 | ||
Short-term hypothermia activates hepatic mitochondrial sn-glycerol-3-phosphate dehydrogenase and thermogenic systems | Q74138733 | ||
Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women | Q80604234 | ||
Photo-DHEA--a functional photoreactive dehydroepiandrosterone (DHEA) analog | Q83364732 | ||
Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis | Q21145774 | ||
Ergosteroids: induction of thermogenic enzymes in liver of rats treated with steroids derived from dehydroepiandrosterone | Q24563604 | ||
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders | Q24613957 | ||
The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative | Q24620663 | ||
Regulation of the adrenal androgen biosynthesis | Q24642693 | ||
Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles | Q24657869 | ||
The biological actions of dehydroepiandrosterone involves multiple receptors | Q24657968 | ||
A structural biology perspective on NMDA receptor pharmacology and function | Q26797461 | ||
The Regulation of Steroid Action by Sulfation and Desulfation | Q26799364 | ||
The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration | Q26830591 | ||
In vivo and in vitro evidences of dehydroepiandrosterone protective role on the cardiovascular system | Q27026337 | ||
Structural Basis for Three-step Sequential Catalysis by the Cholesterol Side Chain Cleavage Enzyme CYP11A1 | Q27666316 | ||
Molecular mechanism of peroxisome proliferator-activated receptor α activation by WY14643: a new mode of ligand recognition and receptor stabilization | Q27684705 | ||
Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital | Q28190299 | ||
An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway | Q28263744 | ||
Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling | Q28290286 | ||
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta | Q28304508 | ||
Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor | Q28307539 | ||
Estrogen biology: new insights into GPER function and clinical opportunities | Q28307726 | ||
The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution | Q28378587 | ||
Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferators | Q28564380 | ||
Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors | Q29616809 | ||
Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase | Q30472059 | ||
Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors | Q33206585 | ||
Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice | Q33358856 | ||
Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging | Q33639450 | ||
The steroid metabolome of adrenarche | Q33699331 | ||
Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging | Q33742113 | ||
Mechanisms of estrogen signaling and gene expression via GPR30 | Q33760458 | ||
Adrenal androgen excess and body mass index in polycystic ovary syndrome | Q41683779 | ||
Dehydroepiandrosterone and alpha-estradiol limit the functional alterations of rat brain mitochondria submitted to different experimental stresses | Q42527682 | ||
Synthesis and application of a photoaffinity analog of dehydroepiandrosterone (DHEA). | Q42920776 | ||
Evaluation of a novel photoactive and biotinylated dehydroepiandrosterone analog | Q42952284 | ||
DHEA, important source of sex steroids in men and even more in women | Q43028516 | ||
Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis | Q43276878 | ||
Expression and regulation of beta-defensin 11 in the oviduct in response to estrogen and in ovarian tumors of chickens. | Q43748270 | ||
Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). | Q43948886 | ||
In vivo activation of the constitutive androstane receptor beta (CARbeta) by treatment with dehydroepiandrosterone (DHEA) or DHEA sulfate (DHEA-S). | Q44249516 | ||
Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11beta-hydroxysteroid dehydrogenases? | Q44384576 | ||
Differential effects of dehydroepiandrosterone and testosterone in prostate and colon cancer cell apoptosis: the role of nerve growth factor (NGF) receptors | Q44395768 | ||
Specific binding of dehydroepiandrosterone to the N terminus of the microtubule-associated protein MAP2. | Q44459214 | ||
Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. | Q44514592 | ||
Dehydroepiandrosterone upregulates neural androgen receptor level and transcriptional activity | Q44615621 | ||
Dehydroepiandrosterone as an inducer of mitochondrial permeability transition | Q44708126 | ||
Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor | Q44926503 | ||
Beneficial effects of the sigma1 receptor agonists igmesine and dehydroepiandrosterone against learning impairments in rats prenatally exposed to cocaine | Q45080373 | ||
No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies | Q45310713 | ||
Neurosteroid dehydroepiandrosterone exerts anti-apoptotic effects by membrane-mediated, integrated genomic and non-genomic pro-survival signaling pathways | Q46242561 | ||
Does DHEA exert direct effects on androgen and estrogen receptors, and does it promote or prevent prostate cancer? | Q46755296 | ||
Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors | Q46884723 | ||
DHEA inhibits vascular remodeling following arterial injury: a possible role in suppression of inflammation and oxidative stress derived from vascular smooth muscle cells | Q46966003 | ||
Dehydroepiandrosterone administration improves memory deficits following transient brain ischemia through sigma-1 receptor stimulation | Q48104624 | ||
Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration. | Q48330721 | ||
Neurosteroids and microneurotrophins signal through NGF receptors to induce prosurvival signaling in neuronal cells | Q48332649 | ||
A new nomenclature for the aldo-keto reductase superfamily | Q48772502 | ||
Intracrinology in action: importance of extragonadal sex steroid biosynthesis and inactivation in peripheral tissues in both women and men. | Q50633502 | ||
Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. | Q50941992 | ||
Inhibition of 7,12-dimethylbenz[a]anthracene- and urethan-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone. | Q51870902 | ||
Modulation of recombinant GABA(A) receptors by neurosteroid dehydroepiandrosterone sulfate. | Q53178752 | ||
Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling | Q33780210 | ||
Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor | Q33820667 | ||
Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. | Q33855409 | ||
Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest | Q33965314 | ||
Dehydroepiandrosterone-induced phosphorylation and translocation of FoxO1 depend on the mineralocorticoid receptor | Q34199583 | ||
The DHEA metabolite 7β-hydroxy-epiandrosterone exerts anti-estrogenic effects on breast cancer cell lines | Q34255080 | ||
DHEA metabolites activate estrogen receptors alpha and beta | Q34309799 | ||
DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology | Q34310104 | ||
The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. | Q34314290 | ||
Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus | Q34377109 | ||
Neurobiology of DHEA and effects on sexuality, mood and cognition | Q34422696 | ||
Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators | Q34424775 | ||
Direct agonist/antagonist functions of dehydroepiandrosterone | Q34430823 | ||
Dehydroepiandrosterone: an ancestral ligand of neurotrophin receptors. | Q34444188 | ||
Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone | Q34631468 | ||
Overview of dehydroepiandrosterone biosynthesis | Q34650156 | ||
The role of NMDA receptors in the pathophysiology and treatment of mood disorders. | Q34664587 | ||
Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice | Q34674280 | ||
Dehydroepiandrosterone decreases the age-related decline of the in vitro fertilization outcome in women younger than 40 years old | Q35166531 | ||
Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36) | Q35802058 | ||
Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells | Q35860722 | ||
Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia | Q35904717 | ||
Neurosteroids and sigma1 receptors, biochemical and behavioral relevance | Q35952478 | ||
The human fetal adrenal: making adrenal androgens for placental estrogens | Q36001095 | ||
Disorders of androgen synthesis--from cholesterol to dehydroepiandrosterone | Q36231631 | ||
Is dehydroepiandrosterone a hormone? | Q36315402 | ||
The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects | Q36394892 | ||
Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development | Q36479015 | ||
Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms | Q36509791 | ||
Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB. | Q36850956 | ||
Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex | Q36854691 | ||
DHEA metabolism in prostate: For better or worse? | Q37153881 | ||
Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone | Q37179141 | ||
Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing rats | Q37214692 | ||
Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). | Q37300547 | ||
Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). | Q37454243 | ||
The role of dehydroepiandrosterone (DHEA) in drug-seeking behavior | Q37708739 | ||
Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology | Q37950023 | ||
Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. | Q38050292 | ||
Role of DHEA in cardiovascular diseases | Q38070054 | ||
Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond | Q38074718 | ||
Genome-wide association studies on serum sex steroid levels | Q38094458 | ||
DHEA and mortality: what is the nature of the association? | Q38202395 | ||
DHEA and cognitive function in the elderly | Q38209249 | ||
Dehydroepiandrosterone, its metabolites and ion channels. | Q38213359 | ||
All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause | Q38219802 | ||
DHEA, DHEAS and PCOS. | Q38227769 | ||
NMDA receptor subunit mutations in neurodevelopmental disorders | Q38286789 | ||
Novel type of Gq/11 protein-coupled neurosteroid receptor sensitive to endocrine disrupting chemicals in mast cell line (RBL-2H3). | Q38328191 | ||
Caveolae and signalling in cancer | Q38388286 | ||
Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer | Q38445141 | ||
Regulation of gene expression by CAR: an update | Q38481059 | ||
The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders | Q38518528 | ||
The G-protein coupled estrogen receptor, GPER: The inside and inside-out story. | Q38550554 | ||
Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features | Q38565775 | ||
Dehydroepiandrosterone Stimulation of Osteoblastogenesis in Human MSCs Requires IGF-I Signaling | Q38810683 | ||
Detection of Isolated Mitochondria-Associated ER Membranes Using the Sigma-1 Receptor | Q38820724 | ||
Non-classical testosterone signaling in spermatogenic GC-2 cells is mediated through ZIP9 interacting with Gnα11. | Q38849566 | ||
Improvement of neuronal bioenergetics by neurosteroids: implications for age-related neurodegenerative disorders | Q38950742 | ||
Dehydroepiandrosterone sulfate mediates activation of transcription factors CREB and ATF-1 via a Gα11-coupled receptor in the spermatogenic cell line GC-2. | Q39103242 | ||
Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channels | Q39385298 | ||
Hydrogen peroxide signaling mediates DHEA-induced vascular endothelial cell proliferation | Q39485361 | ||
Prevention of obesity in Avy/a mice by dehydroepiandrosterone | Q39815919 | ||
PPP1R16A, the membrane subunit of protein phosphatase 1beta, signals nuclear translocation of the nuclear receptor constitutive active/androstane receptor | Q40023868 | ||
Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study. | Q40717193 | ||
Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor. | Q40738577 | ||
Dehydroepiandrosterone stimulates the estrogen response element | Q41095142 | ||
Inhibition of the GABAA Receptor by Sulfated Neurosteroids: A Mechanistic Comparison Study between Pregnenolone Sulfate and Dehydroepiandrosterone Sulfate | Q41335364 | ||
Steroidogenic acute regulatory protein: the StAR still shines brightly | Q41667110 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | R139-55 | |
P577 | publication date | 2016-02-23 | |
P1433 | published in | Journal of Molecular Endocrinology | Q15716709 |
P1476 | title | Novel mechanisms for DHEA action | |
P478 | volume | 56 |
Q46328577 | Aggressive behaviours track transitions in seasonal phenotypes of female Siberian hamsters |
Q55344917 | Androgen Regulation of the Mesocorticolimbic System and Executive Function. |
Q55357541 | Androgen-Induced Immunosuppression. |
Q33917191 | Androgenic potential of human fetal adrenals at the end of the first trimester |
Q57458436 | Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential? |
Q92702133 | Comprehensive Circulatory Metabolomics in ME/CFS Reveals Disrupted Metabolism of Acyl Lipids and Steroids |
Q92931903 | DHEA Inhibits Leukocyte Recruitment through Regulation of the Integrin Antagonist DEL-1 |
Q90732597 | DHEA Treatment Effects on Redox Environment in Skeletal Muscle of Young and Aged Healthy Rats |
Q47819819 | DHEA inhibits acute microglia-mediated inflammation through activation of the TrkA-Akt1/2-CREB-Jmjd3 pathway |
Q90479288 | DHEAS and Human Development: An Evolutionary Perspective |
Q48516030 | Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study |
Q92463404 | Dehydroepiandrosterone: a potential therapeutic agent in the treatment and rehabilitation of the traumatically injured patient |
Q90325378 | Effect of dehydroepiandrosterone on meiotic spindle structure and oocyte quality in mice |
Q92257238 | Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension |
Q89452084 | Estrogenic control of mitochondrial function |
Q39236899 | Estrogens regulate life and death in mitochondria |
Q92857748 | Fatigue, Sleep, and Autoimmune and Related Disorders |
Q92512475 | Modulation of plasma and urine metabolome in colorectal cancer survivors consuming rice bran |
Q57170039 | Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature |
Q90077292 | Neurosteroids as regulators of neuroinflammation |
Q90164308 | Physical Activity and Brain Health |
Q92432691 | THE RARE CASE OF MIXED GONADAL DYSGENESIS, MOSAIC KARYOTYPE, PETROCLIVAL MENINGIOMA AND IDIOPATHIC HYPERDEHYDROEPIANDROSTERONISM |
Q98735476 | The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases? |
Q90227619 | The Roles of Sex Hormones in the Course of Atopic Dermatitis |
Q100946045 | The antiandrogenic vinclozolin induces differentiation delay of germ cells and changes in energy metabolism in 3D cultures of fetal ovaries |
Q54941492 | The tempo of human childhood: a maternal foot on the accelerator, a paternal foot on the brake. |
Q97070248 | Unravelling the role of epigenetics in reproductive adaptations to early-life environment |
Search more.